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ABSTRACT
Background: Exposure therapy (EXP) is a first-line intervention for combat-related
PTSD. EXP works by repeatedly exposing the patient to the feared stimuli, situation, or physical
sensations in the absence of actual danger until the stimuli no longer evoke maladaptive
responses. Over the past decade, multiple technologies have been introduced to augment the
EXP process by presenting multi-sensory cues (e.g., sights, smells, sounds) to increase patients’
sense of presence. Exploratory research has only broadly examined the effect of odorants on the
patient’s sense of presence during simulated exposure tasks. This study hypothesized that those
with autobiographical memories similar to the virtual environment (VE) and those who received
odorants would report experiencing more presence than experimental controls. Methods: 61
veterans and civilian subjects were randomized and asked to participate in a virtual environment
simulating a routine OIF/OEF/OND convoy. The effects of odorants and autobiographical
memory on presence were assessed via electrodermal activity, respiration, heart rate variability,
and self-report measures. Results: Odorants did not significantly influence presence. A
relationship between military experience and presence, HRV, and realism was observed.
Conclusion: Odorants did not have a statistically significant effect on presence while engaged in
a simulated exposure task, which was inconsistent with previous research. The rationale for these
findings and recommendations for future research are made.
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INTRODUCTION
Posttraumatic Stress Disorder
Posttraumatic Stress Disorder (PTSD) has been called one of the “signature wounds of
the Iraq war” (Tanielian & Jaycox, 2008), with prevalence currently estimated at over 13% of
operational infantry forces and 5% of total deployed forces (Kok, Herrell, Thomas, & Hoge,
2012). The high prevalence within operational units represents significant demand for mental
health service providers. However, providing care for service members may be challenging due
to stigma (Hoge et al., 2004; Kim, Thomas, Wilk, Castro, & Hoge, 2010), limited appointment
availability (Sareen et al., 2007), and negative perceptions of care (Kim, Britt, Klocko, Riviere,
& Adler, 2011; Sudom, Zamorski, & Garber, 2012) which appear to result in an overall
treatment reach that is limited (Hoge et al., 2014).
Olesen, Gustavsson, Svensson, Wittchen, and Jönsson (2012) estimated the approximate
annual cost of PTSD to be $10 trillion dollars in Europe alone. The Congressional Budget Office
reported the direct cost of treating PTSD in American warfighters (a minuscule subset of the
overall US population) between 2004-2009 was approximately 1.4 trillion dollars (Bass &
Golding, 2012). Lépine (2002) has suggested additional, indirect expenses (such as reduced
productivity and absenteeism) increase costs associated with mental health disorders. In addition,
PTSD is also often compounded by other medical needs (Frayne et al., 2011) as well as
depression (Campbell et al., 2007), which further increase the financial burden tied to mental
health.
Some of the symptoms associated with PTSD are part of the normal reaction to trauma.
These include difficulty concentrating or sleeping, as well as intrusive and trauma-related thoughts
or images. Many people who experience a traumatic event naturally recover as demonstrated by a

decline in distress over time. In a civilian sample, nearly 90% of adults reported experiencing a
traumatic event, but only a small subset developed PTSD (Kilpatrick et al., 2013). A DSM-5
diagnosis of PTSD requires symptoms to be present for at least 30 days and requires clinically
distressing symptoms be present across five criteria, including a) exposure to actual or threatened
death, serious injury, or sexual violence, b) intrusive symptoms, including thoughts or memories,
c) avoidance of reminders of the event, d) cognition and mood symptoms, such as difficulty
remembering important aspects of the event, or persistent negative expectations, and e) arousal or
reactivity symptoms, which include irritability and hypervigilance (American Psychiatric
Association, 2013).
While PTSD is no longer classified as an anxiety disorder, behavioral avoidance in PTSD
is similar to that seen in anxiety disorders such as panic or specific phobias. Avoidance of traumarelated reminders prevents distressing memories from arising, preventing anxious and fearful
thoughts and negative feelings associated with the traumatic memory. Unfortunately, avoiding
thoughts and feelings associated with the event prevents those suffering from PTSD from learning
new and more adaptive response patterns (Foa, Huppert, & Cahill, 2006; Foa & Kozak, 1986).
Ehlers and Clark (2000) have described avoidance as a maladaptive control strategy which
short-circuits disconfirmation of negative appraisals. This failure to allow disconfirmation results
in the maintenance of the perceived threat. Behavioral avoidance has been seen in various
populations with PTSD, including combat veterans (Pietrzak, Harpaz-Rotem, & Southwick, 2011),
victims of sexual assault and abuse (Fleurkens, Rinck, & van Minnen, 2014), and motor vehicle
accident victims (Delahanty et al., 1997). By encouraging patients to face anxiety-provoking
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situations, thereby preventing the avoidant behavior, incompatible and erroneous information can
be corrected with more appropriate behavioral responses that enable better daily functioning.
Exposure Therapy
Exposure therapy (EXP) is an empirically supported treatment for anxiety disorders (Opriş
et al., 2012; Parsons & Rizzo, 2008) and PTSD (Powers & Emmelkamp, 2008; Powers, Halpern,
Ferenschak, Gillihan, & Foa, 2010). EXP is an intervention grounded in the principles of classical
conditioning as observed by Pavlov (1902) and Watson and Rayner (1920) and is similar to fear
extinction models used in animals (Myers & Davis, 2007). An example of classical conditioning
in combat-related PTSD might include avoidance of crowds after experiencing the detonation of
an improvised explosive device (IED) in a crowded market, which threatened the life of the patient.
The goal of EXP is to extinguish behaviors that are (or have become) maladaptive, by exposing
the patient to the anxiety or fear-producing stimulus (or a facsimile of that stimulus) without
exposing the patient to actual danger. Stimuli constellations are often perceived as harmless to
outside observers but serve as “triggers” or, put more formally, fear-structures that are perceived
as highly dangerous by warfighters with PTSD. In the IED example used earlier, this constellation
might include the scent of smoke, diesel, and body odor, accompanied by tactile vibrations and
loud explosions. By activating these fear-structures in the absence of danger or negative outcomes,
corrective information acts upon and modifies the pathological component of the fear structure
until the patient no longer experiences the distressing symptoms, thoughts, or emotions. This
process allows new information and more adaptive expectations to be learned. EXP can be
conducted both imaginally (where the patient imagines the feared stimulus or situation), and in
vivo (in life, where people are physically engaged with a facsimile of, or the actual feared stimulus
or situation).
3

Including multiple sensory modalities during EXP (either imaginal or in vivo) that are
associated with the stimulus or situation appear to enhance learning (Rescorla, 2006). Recently,
researchers utilizing EXP for PTSD have increased utilization of multimodal sensory systems
during EXP to create high fidelity virtual environments (VEs) for use in EXP (Gerardi, Cukor,
Difede, Rizzo, & Rothbaum, 2010; McLay et al., 2011; Rizzo et al., 2009; Rizzo, Reger, Gahm,
Difede, & Rothbaum, 2009). These multi-sensory systems include 3D visuals, sounds, tactile
feedback (platforms that vibrate during explosions, for instance), and odorants (such as the scent
of diesel fuel). The inclusion of multiple stimuli serves multiple purposes, which includes reducing
mental strain required to imagine or visualize the event, and reducing patient avoidance. Both
behavioral and cognitive avoidance are common in patients with PTSD and counteract the
theoretical mechanisms of EXP by limiting exposure to conditioned stimuli (CS) in the absence of
unconditioned stimuli (US). The direct delivery of multisensory and trauma-related cues helps to
circumvent patient avoidance. The inclusion of multiple trauma-related stimuli may also increase
a patient’s degree of presence during EXP.
Presence
Presence was first formally defined by Sheridan (1992) as “the sense of physically being
present with visual, auditory, or force displays generated by a computer.” He proposed that
presence is a subjective state produced when subjects are provided high-fidelity sensory
information, the ability to change the environment, and willingness to engage with the VE. The
term presence is not unified in its use, and several competing definitions and conceptualizations
exist, which are examined in Lombard and Ditton (1997) and more recently, Procci (2015).
These conceptualizations include presence as realism, or the capability of a system to produce
high fidelity reproductions of real-world objects (Hatada, Sakata, & Kusaka, 1980; Neuman,
4

1990). The conceptualization of realism defined presence as a system’s ability to create virtual
objects that have high degrees of fidelity to their real-world counterparts. Presence has also been
thought of as transporting an audience to another time/place through various mechanisms (e.g.,
narratives, storytelling, or television) where users feel as though they are physically somewhere
they are not (Biocca & Delaney, 1995; Gerrig, 1993; Minsky, 1980; Reeves, 1991). Presence as a
social actor (Lombard, 1995) is perhaps one of the conceptualizations public consumers are most
familiar with, though they may not be aware of it. Many smartphones currently implement
virtual assistants (e.g., Apple’s Siri, Microsoft’s Cortana, and Amazon’s Alexa) capable of
“interacting” with users. According to the social actor conceptualization, users who interact with
these programs, as they would with actual people, experience presence. Presence has also been
conceptualized as (and sometimes used interchangeably with the terms) perceptual or
psychological immersion (Lombard & Ditton, 1997). Contemporary definitions of presence state
that presence is caused by (as quoted in Procci, 2015, p. 247):
•

…high levels of overall immersion, a combination of:

•

Immersive cues provided by the video game (e.g., high-fidelity, increased field of
view, HMD, naturalistic inputs, etc.)

•

Lots of immersive cues make it easier to confirm and needs more distractions to take
away

•

Personal involvement and motivation to be present

•

Creative imagination and willingness to suspend disbelief
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As the definitions of presence and immersion solidified in the early 2000’s, the accurate
measurement of presence began to be explored. IJsselsteijn, De Kort, Poels, Jurgelionis, and
Bellotti (2007) reviewed methodologies used to assess presence, including subjective and
objective methods. Subjective measurements included self-report rating scales and
psychophysical ratings. Several self-report measures are currently in use for measuring presence,
including the Presence Questionnaire (Witmer & Singer, 1998) and the iGroup Presence
Questionnaire (Schubert, Friedmann, & Regenbrecht, 2001). For psychophysical ratings, users
are asked to determine if a location in a photo is real or that of a VE (Schloerb, 1995); however, it
is important to note that the psychophysical rating method has been criticized in its ability to
assess presence rather than simply an ability to judge images as rendered or real (IJsselsteijn et
al., 2007). One important point offered by IJsselsteijn and colleagues is that subjective measures
often fail if participants or subjects fail to understand the definition of presence and that
objective measures that correlate to subjective measures are useful when assessing presence. The
authors specifically noted the use of physiological measures to quantify presence, such as heart
rate (HR) and galvanic skin response (GSR; now referred to as electrodermal response activity or
EDA). The rationale for these two specific physiological methods is EDA’s association with
arousal, and HR’s association to hedonic value, in which pleasant stimuli decrease heart rate and
aversive stimuli increase heart rate. Unfortunately, the value of EDA is unknown, as mixed
results have been reported in the literature (Drachen, Nacke, Yannakakis, & Pedersen, 2010;
Wiederhold, Davis, & Wiederhold, 1998).
It has been argued that presence is of critical importance when using VEs in
psychotherapy (Sanchez-Vives & Slater, 2005) but the relationship between presence and VEs
utilized in exposure therapy is currently poorly understood. Which elements are critical to evoke
6

a presence response, and what fidelity is required? Display parameters, visual realism, sound,
haptics, body representation, and engagement have been the most explored areas pertinent to
presence (see Sanchez-Vives & Slater, 2005 for a review), while olfaction’s effect on presence
has generally received less attention (Aiken & Berry, 2015).
Olfaction
The ability to smell is found in almost all animal species (Wilson & Stevenson, 2006).
Olfaction provides information that is particularly important in many daily functions, such as the
detection and identification of food. Scents or odorants may be environmental (soil, minerals) or
biological (pheromones). Simply stated, the primary function of the olfactory system is to permit
an organism to identify odorants. This is accomplished through receptor cells and membranes
that respond to chemical molecule compositions. For some odorants, the amount of chemical
required for detection can be minuscule but can provide critical information relevant to the
organism’s survival. While seemingly simple, the process of olfaction is mechanically complex,
and the perception of odorants depends on not only on the detection of chemical compounds but
also one’s expectations and contextual information.
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Figure 1: Schematic Diagram of the Olfactory System
Note: The connection between olfactory bulb and the hypothalamus is not established in humans. Used
with permission by Cambridge University Press.

Olfaction begins within the nasal cavity at the olfactory bulb, where 5-15% of inhaled air
is diverted towards receptors (Keyhani, Scherer, & Mozell, 1995). There are an estimated six
million olfactory receptor cells within each nostril (Moran, Rowley III, Jafek, & Lovell, 1982),
which are situated in the olfactory epithelium (Figure 1). These cells are the primary receptors of
the olfactory system and serve sensory information to the olfactory bulb, which filters and
modifies sensory information.
Information is then sent from the olfactory bulb to the primary olfactory cortex (POC)
and the amygdala. The POC is comprised of the 1) anterior olfactory nucleus, 2) piriform and
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peri amygdaloid cortices, 3) olfactory tubercle, and 4) entorhinal cortex. The anterior olfactory
nucleus appears to regulate information flow between regions dealing with olfactory information
(Brunjes, Illig, & Meyer, 2005). The piriform cortex has been implicated in odor recognition
(Dade, Zatorre, & Jones‐Gotman, 2002; Plailly et al., 2005), representation of odor properties
(Gottfried, Winston, & Dolan, 2006), odor valence (Gottfried, Deichmann, Winston, & Dolan,
2002) and odor attention (Zelano et al., 2005), while the peri amygdaloid and entorhinal cortices
assist in the processing of olfactory information (Biella & de Curtis, 2000; Majak & Pitkanen,
2003). Information processed by the POC is then passed to the thalamus and hippocampus, while
other information is passed directly from the olfactory bulb to the amygdala.
The olfactory system has the most direct connection to the hippocampus (synaptically)
compared to all other sensory systems. It is largely accepted that the hippocampus is involved in
the formation of memories about experienced events (Burgess, Maguire, & O'Keefe, 2002;
Eichenbaum, 1993). It has also been suggested that the hippocampus and amygdala act in unison
when emotion and memory are connected. Phelps (2004) describe the amygdala’s function in
modulating the encoding and storage of hippocampal-dependent memories. This is in addition to
the hippocampus’ influence on amygdala responses when emotional stimuli, such as those
encountered during traumatic events, are presented.
The power of odorants is often anecdotally discussed when discussing memories. It has
been suggested that scents are strong cues for memories past, a connection first described in
Swann’s Way (Proust, 1925). Research has demonstrated that odorants result in memory recall
with greater emotional potency than verbal or visual stimuli (Chu & Downes, 2000; Chu &
Downes, 2002; Herz, 1998; Herz & Cupchik, 1995; Herz & Engen, 1996). The connection
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between odorants and memory has, more recently, been leveraged in exposure therapy with
combat veterans. For warfighters who served in OIF/OEF/OND, odorants such as cordite,
burning rubber, garbage, and diesel fuel have been used (Rizzo et al., 2010; Rizzo et al., 2008).
The effect of war-related odorants on veterans is not new; Kline and Rausch (1985) described
how war-related odorants served as precipitants of flashbacks in Vietnam veterans. More
recently, Vermetten and Bremner (2003) presented a vivid example of the emotional impact
odorants can have when paired with traumatic events:
I found my wife out on the back deck watching a fire that was about 300 feet
away. This is when I noticed the smell of burning rubber, together with a faint smell of
fuel oil or diesel oil. My wife stated she was worried about me because I was standing on
the deck as if I was daydreaming for some minutes without responding to her. The smell
brought to my mind the image of this burning Amtrak, again so vivid. The Amtrak was
hit. The front door/ramp was open; both crew hatches were open and pouring out smoke
and flame. Thick, black, acid smoke was boiling out of the troop compartment. There was
an overpowering smell of burning rubber. I remember that smell and what it looked like
that day vividly. There was nothing I could have done to save the people in the Amtrak.
Fifteen Marines and three crew members died there that day. I felt the same hopelessness
as I felt that day. I felt bad in my stomach, got a headache, and had a feeling of futility or
finality when I thought about that incident (page 203, paragraph 3).
While the link between odorants and memory appears to be generally accepted, little
research has focused on the effect of odorants on veterans’ sense of presence during EXP. While
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odorants have been shown to increase presence in more general VE’s (Dinh, Walker, Hodges,
Song, & Kobayashi, 1999), the study did not examine the link within a treatment specific context.
Memory
Autobiographical memory has been defined as the mental representation of events from
one’s past and includes semantic information about one’s self (Conway, 2005). Those with
PTSD are often able to recall vivid details about their respective traumatic events. When
discussed, it appears that presence is often assessed with little regard to a users’ autobiographical
experience or memory within the virtual environment. Instead, the extant literature appears to
examine a user's ability to recall aspects of a virtual environment after an experiment which
manipulated odorants has concluded. For example, Dinh, Walker, Hodges, Song, and Kobayashi
(1999) examined sensory factors that increased user’s recall of a VE. Similarly, researchers have
compared perceived presence between real, HMD, and audio-only conditions, but failed to
address previous experience (Mania & Chalmers, 2001). Limited research has only anecdotally
noted significant differences in combat-related behaviors which trended with actual experience,
which may suggest memory or experience is drawn upon by users when engaging with a VE
(Kaber et al., 2013). Unfortunately, presence was not a variable of interest within that study. This
dearth of information regarding the effect of memory or experience upon presence is important
for clinical interventions based on exposing a patient to a VE rooted in autobiographical
memory.
Understanding the relationship between memory, presence, and olfaction may result in
improved intervention planning and treatment outcome. If personal experience influences
presence, special attention may be required to ensure the deployment of VE’s congruent with
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patient memories. Similarly, if odorants enhance the sense of presence in veterans and service
members in an environment during simulated exposure tasks, it seems logical that exposure
therapy may be more effective when olfactory cues are added. This study hypothesized the
following:
1) Participants who received odorants during a simulated task would
experience greater levels of presence than those who did not receive
odorants. This finding would replicate the findings of Munyan, Neer,
Beidel, and Jentsch (2016).
2) Participants who received odorants during simulated tasks would have
differing levels of physiological activity than those who did not
receive odorants. It was expected that increased presence might place
an increased demand upon the autonomic nervous system, which may
then be observed via increased anxiety and/or arousal.
3) Veterans would experience greater levels of presence than noncombat
civilian controls, regardless of odorant condition. We expected that
combat experience or autobiographical memory similar to the VE
would cause participants to feel greater presence than those without
similar experiences.
4) Veterans would experience greater EDA levels and HRV than
noncombat civilian controls, regardless of odorant condition. We
expected veterans would engage with the VE to a higher degree than
their noncombat peers given their experience in potentially dangerous
12

situations. We believed their experience in real-world combat zones
might have driven increased ANS activation.
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METHODS
This study asked participants to navigate a VE identical to those currently being used in
the treatment of combat-related PTSD (Rizzo, Hartholt, Grimani, Leeds, & Liewer, 2014). We
immersed the user in a mildly anxiety-producing situation (a military convoy along a potentially
dangerous route) in order to simulate the arousal seen in patients during exposure therapy, albeit
at a non-clinical level. After the informed consent process, participants completed questionnaires
to acquire demographic information as well as data related to their immersive tendencies and
state anxiety. They were then fitted with electrodes connected to the physiological recorder and
assisted into the virtual reality equipment by experiment staff. The initial virtual area participants
experienced allowed them to familiarize themselves with the head-mounted display (HMD) prior
to the experiment beginning. After a five-minute baseline period, pre-recorded instructions were
delivered to the participant via headphones. Once they indicated that they were ready to begin,
the exposure task began. The VE exposure task lasted approximately 10 minutes.
Veteran participants and civilian noncombat controls were randomized to either an odorant
condition or a control (no odorant) condition (See Figure 2).
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Figure 2: Experiment Design

Participants
Online and community announcements were made in the Orlando, Florida area.
Recruiting announcements included flyers and announcements to online veterans, military, and
community groups as approved by the IRB. A total of 232 potential participants completed the
online prescreen assessment. Reasons for disqualification included the following: 18 had PCL-5
scores above the utilized cutoff of 33, 17 were ineligible due to tobacco use, 5 reported current
illness during the experiment window, 4 reported some degree of anosmia, and 2 had a history of
seizures and/or epilepsy. Of the remaining potential participants, 125 did not return requests
made by the experimenter to schedule participation times. Participant flow can be seen in Figure
3.
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Figure 3: Participant Flowchart
The final sample consisted of 61 adult males between the ages of 17 and 61 (M = 25.2,
SD = 9.68.) The sample was predominately white (61%) and included participants of Latino
(13%), Asian (11%), Black (7%), and other (8%) races. Demographic information can be viewed
in Table 1.
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Table 1: Demographic Information
Race

n

Military Branch (if applicable)

n

White
Latino
Asian
African American
Other
American Indian or Alaska Native
Native Hawaiian or Pacific Islander
Education
High School Diploma / GED
Associates Degree
Bachelor’s Degree
Graduate Degree

37
8
7
4
3
1
1
n
37
15
4
5

Army
Air Force
Marines
Navy

15
4
3
3

Marital Status
Single/Never Married
Married
Divorced

n
43
14
4

Both the military and civilian control groups were queried about previous experiences
that may have been similar to the VE to ensure distinctiveness between-groups and verify the
degree of fit between the VE and the participants' background. For example, those with military
backgrounds were asked to report the number of times they had deployed, their total time spent
deployed, where they deployed, and other details pertaining to their service as they related to the
VE. All veteran or military participants reported taking part in convoy operations during
deployments to the Middle East in support of operations OIF/OEF/OND. Within this sample,
52% reported deployments to Iraq (n = 13), Afghanistan (n = 7, 28%), and other countries in the
region (n = 5, 20%). Discrete periods of overseas deployment ranged from one to seven (M =
2.04, SD = 1.45) with total time spent deployed ranging from 6 to 48-months (M = 12.16, SD =
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23.46). Within the military groups, 72% reported the primary vehicle utilized during convoy
operations was a HUMVEE or a HUMVEE variant (n = 18).
Similar questions were asked of the civilian control sample to ensure no analogous
experiences might confound data analyses. Specifically, civilian controls were asked if they had
been employed in any position that entailed driving or commuting long distances. No control
participants endorsed a history of such employment. Control participants were also asked if they
had ever served in a capacity that may have exposed them to traumatic events, such as an EMT,
first responder, firefighter, or police officer. Again, no controls endorsed employment or
personal experience within these fields of work/training.
Measures
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
The Clinician-Administered PTSD Scale (CAPS) for DSM-5 (Weathers et al., 2013) was
used to assess PTSD symptomology in participants. The CAPS interview is a 30-item
semistructured interview used to assess both the frequency and intensity of PTSD symptoms and
is the “gold standard” for assessing PTSD symptoms. The CAPS was administered to
participants scoring a 33 or greater on the PCL-5 (see below) to determine if participants were
experiencing symptoms with intensity and frequency consistent with PTSD. Scores obtained on
the CAPS were not used for inclusion/exclusion decisions. Instead, DSM-5 diagnostic criteria
were used to determine clinical appropriateness for this study.
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PTSD Checklist for DSM-5 (PCL-5)
The PTSD Checklist for DSM-5 (PCL-5; Blevins, Weathers, Davis, Witte, & Domino,
2015) is a 20-item self-report that assesses the 20 symptoms of PTSD in accordance with DSM-5
diagnostic criteria. The PCL-5 is frequently used for monitoring symptom change and screening
for PTSD. Symptom severity scores range from 0-80, with each item being rated 0 (none) to 4
(all the time). The PCL-5 was administered for all participants as a PTSD screening measure.
Those who scored above a 33 (Wortmann et al., 2016) were further assessed via the CAPS by the
principal investigator.
Quick Smell Identification Test (QSIT)
The QSIT (Sensonics, Inc., Haddon Heights, NJ) is a 3-item, forced-choice test that uses
microencapsulated odorant strips to determine olfactory function (Doty, Shaman, Kimmelman, &
Dann, 1984) and is capable of detecting unsophisticated malingering, partial anosmia, and total
anosmia. The QSIT allows researchers to identify individuals who possess abnormal olfactory
function that may otherwise confound experimental results.
State-Trait Anxiety Inventory (STAI)
The State-Trait Anxiety Inventory (Spielberger, 1983) is a 40-item, self-report measure
designed to measure both the transient state of arousal subjectively experienced as anxiety and the
more constant emotional presence of anxiety. It has good psychometric properties (Speilberger &
Vagg, 1984) and has a response burden of approximately ten minutes. The STAI assesses items
based on a four-factor structure comprised of two primary factors: state anxiety and trait anxiety.
Items on the STAI range from “I am Calm” (State Anxiety) to “I worry too much over something
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that doesn’t matter” (Trait Anxiety). The trait anxiety portion of the STAI served as a covariate
for trait anxiety.
Igroup Presence Questionnaire (IPQ)
The Igroup Presence Questionnaire is a 14-item self-report questionnaire designed to
measure presence utilizing a 7-point Likert scale (Schubert et al., 2001) that loads onto three
subscales; spatial presence (the sense of physically being in the virtual environment), involvement
(focus on the VE and involvement experienced), and experienced realism (subjective realism of
the VE). The involvement and experienced realism subscales may be particularly relevant to
exposure therapy as VR seeks in engage patients in a realistic way. Items range from “How aware
were you of the real world while navigating in the virtual world?” to “How real did the virtual
world seem to you?” IPQ scores were the primary outcome measure for this study.
Immersive Tendencies Questionnaire (ITQ)
The Immersive Tendencies Questionnaire (Witmer & Singer, 1998) is a 29-item self-report
measure designed to assess individual tendencies towards immersing in different mediums, such
as books, television, and video games. The items in this questionnaire measure the participant’s
involvement in many different daily activities, such as watching television, reading books, or
enjoying movies. As involvement can result in more immersion, those who become more involved
may also have greater immersive tendencies. The ITQ served as a covariate in presence-related
analyses unless otherwise indicated.
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Presence Visual-Analogue Scale (PVAS)
Participants were asked to rate their level of immersion during the experiment to determine
presence on a visual-analog scale (VAS). Visual analog scales have been demonstrated to
accurately assess anxiety (Davey, Barratt, Butow, & Deeks, 2007). It has been shown that VASs
have moderate to strong correlations with Likert-based items (Hasson & Arnetz, 2005). VASs have
superior metrical characteristics than discrete scales and can have a wider range of statistical
methods applied to their measurements (Reips & Funke, 2008).
Presence Rating Scale (PRS)
Participants were asked to rate their current level of presence during scripted events within
the exposure task. This rating was on a 7-point Likert scale to remain consistent with the Likert
scale of the IPQ. The question, “How present do you feel?” was anchored at one (not at all) and
seven (very much). The PRS was assessed verbally as to minimize the disruption of assessing
presence during an experimental task, which can actually reduce perceived presence if done in an
intrusive manner (such as visually).
Simulator Sickness Questionnaire (SSQ)
The Simulator Sickness Questionnaire was developed by Kennedy, Lane, Berbaum, and
Lilienthal (1993). It is a 16-item self-report scale used to rate common symptoms of simulator
sickness on a 4-point scale. Such symptoms include general discomfort, headache, eyestrain,
sweating, and vertigo. Information about the user’s present state of health was solicited before and
after utilizing the VR equipment to assess symptoms commonly associated with VR use. The SSQ
was used to ensure participant health was not compromised as a result of research participation.
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Electrodermal Activity (EDA)
EDA measures the electrical conductance of the skin, which is made possible by sweat
glands controlled by the sympathetic nervous system. EDA was used as an objective measure of
psychophysiological activity and was assessed utilizing a Mindware MW3000A Bio-Potential
and EDA Monitor. Silver-chloride cup electrodes were placed on the nondominant palm in
accordance with best practices (Carlson, 2013). Data were collected with BioLab Acquisition
Software and inspected visually during the experiment by either the principal investigator or a
research assistant trained by the principal investigator. After the experiment, the signal was
amplified 10x and processed through a 1 Hz Low Pass filter to remove artifacts caused by
movement. All physiological data were inspected, corrected, and analyzed in EDA (Mindware
Technologies LTD, Gahanna, OH) by the principal investigator. EDA served as an objective,
physiological indicator of anxiety and sympathetic nervous system activation. Skin Conducance
Reactions (SCRs) were defined as a 0.05uS increased between between 1-3 seconds post event.
Heart Rate Variability (HRV)
HRV is perhaps most simply described as the variation between heartbeat intervals. In
recent years, HRV has been utilized as a selective index of parasympathetic control (compared to
EDA, which is widely under sympathetic control). We assessed activation of both the
sympathetic and parasympathetic influences on the autonomic nervous system to gain insight
regarding the olfactory stimuli physiological influence. HRV was assessed with a MW3000A
Bio-Potential Monitor. HRV served as a second objective, physiological indicator of anxiety,
with less variability indicating an increased parasympathetic response. Specifically, respiratory
sinus arrhythmia (RSA) was assessed, which is the naturally occurring variation in heart rate
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during the breathing cycle. RSA serves as a measure of parasympathetic nervous system (PNS)
activity. High-Frequency Power (HF/RSA Power) was used as a frequency-domain measurement
to observe the 0.15 to 0.4 Hz band, which is thought to indicate PNS activity.
Odorant Ratings (Intensity, Valence, Familiarity)
Subjects were asked to rate the intensity, valence (pleasantness), and familiarity of the
odorants using a 7-point Likert scale anchored at -3 (Extremely Unpleasant) to 3 (Extremely
Pleasant). Intensity (Undetectable, Intolerable) and familiarity (Unfamiliar, Very Familiar) were
rated on a similar 7-point scale.
Qualitative Feedback
Military participants were asked to provide feedback about the virtual environment.
Specifically, they were prompted to provide insight into the degree to which the VE was
consistent with their actual experience. This feedback allowed us to determine which aspects of
the VE were effective and which elements may be improved upon for future research. Elements
are deemed ineffective if they were distracting, out of place, incorrect, or otherwise detracted
from the user experience.
Procedures
Informed consent was obtained by approved study personnel prior to participation as
approved by the University of Central Florida (UCF) Institutional Review Board. Confidentially
and its limits was reviewed prior to the pre-screen assessment as well as prior to experimental
participation. Rights, including the right to withdraw, were discussed to ensure subjects
understood prior to data collection. Participants were provided ample time to ask questions
during informed consent and throughout each stage of the experiment if needed.
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Following consent, subjects were asked to complete self-report measures and
demographic questionnaires on an Amazon Fire 7” tablet (Amazon Inc, Seattle, WA.) They were
then connected to the MW3000A physiological recorder and equipped with the VR equipment.
After the experimenters ensured all systems were functioning correctly, volunteers were given a
five-minute baseline period to familiarize themselves with the HMD and the VE. After this
baseline period, they were informed that the experiment would begin momentarily and given the
following set of instructions:
We are going to begin. During the experiment, we are going
to present you with a virtual reality scene. Elements of the environment
will be described to you in detail. Your job is to imagine yourself in the
environment exactly as it is presented. Please remain focused on the
scene; particularly, do not imagine anything that would make you feel
more comfortable or relaxed. At certain points, you will be asked to rate
how much you feel you are immersed in the environment or in other
words, how much you feel you are really there. We will use the 1 to 7point scale where 1 is “not at all” and 7 is where you feel “completely”
immersed. When you are asked for your rating, try to give me the rating
as truthfully and as quickly as possible. Your rating is very important.
You will be notified when the experiment is over and given further
instructions. Do you have any questions before we begin?
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Baseline physiological data was collected during a discrete 5-minute period. The last 60
seconds of the baseline window was utilized as a control for physiological analyses to control for
individual differences. Physiological data was collected continuously over the duration of the 8minute exposure simulation, as seen in Figure 4.

Figure 4: Experimental Task Timeline

Virtual Reality System
The odorants used were ceramic pellets impregnated with scented oil (Dreamreapers Inc.,
Melrose Park, IL). Scents were those commonly utilized in exposure therapy for combat-related
PTSD, including diesel fuel, garbage, smoke, and body odor. Air charged with odorants was
delivered via air dispersion by a USB controlled Scent Palette (Virtually Better Inc., Decatur,
GA). During the experimental trial, 50% (n = 30) of participants received odorants congruent
with the VE; the other half (n = 31) of participants did not receive odorants.
The VE (Bravemind, Institute for Creative Technologies, USC, Pasadena, CA) was
modeled in 3D and controlled with the Unity3D engine (Unity Technologies, San Francisco, CA)
and approximated a military convoy as it traveled through urban and rural environments
approximating those of Iraq and Afghanistan. Participants were asked to imagine that they were
on a convoy mission which included visual and auditory cues such as burning trash, ambient
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noises, and other environmental factors. The VE was presented to the subject using a Sony
HMZ-T3 HMD (Sony Corp., Tokyo, Japan) and high-fidelity stereo headphones (Audio
Technica ATH-M50x; Audio Technica, Stow, Ohio). The VE was presented by a PC with an
Intel® i5-4670 3.4 GHz CPU, 16 gigabytes of RAM, and a Nvidia® GTX 780 Tic GPU.
Participants were navigated through the VR environment at a pace matched to auditory
descriptions of the scene. Participants did not have navigational control of their avatar for this
experiment. Scripted events were presented to add realism to the VE. For example, a helicopter
and A10 Thunderbolt flew over participants with a matching audio sample. Later, a burning
vehicle on the side of the road was displayed as the participant passes an urban environment. For
those in the odorant condition, this scene was augmented with the scent of smoke. Upon
completion of the VE task, participants were assisted out of the physiological and VR equipment
and then asked to complete questionnaires regarding their experience within the VR. Upon
completing these questionnaires, volunteers received either SONA credit or an Amazon gift card
as compensation, concluding their participation in this study.
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RESULTS
Statistical Analyses
All statistical analyses were conducted on the final sample (n = 61) using JMP Pro 13.0.0
(SAS Institute Inc., Cary, NC) after screening for data normalcy. All analyses defined
significance with a p-value ≤ 0.05 unless otherwise specified. All Linear Mixed Models (LMMs)
utilized a Kackar and Harville (1984) correction to reduce bias and correctly estimate standard
errors for the utilized sample size.
Data Screening
Jackknife distance measures were calculated to identify multivariate outliers utilizing the
critical value formula recommended by Penny (1996). Two such outliers were found with critical
values greater than 3.82. All analyses were conducted with outliers both included and excluded
to assess their influence on the mixed model. These analysis comparisons showed that while
outliers had a small impact upon significance p-values, they did not possess enough influence to
alter the significance of any analyses. Thus, the outliers were included in the results reported
here.
To detect group differences in age, a one-way ANOVA was used which revealed
statistically significant differences between participant groups, F(3,56) = 15.97, p < 0.0001. A
Tukey-Kramer HSD was used to further delineate where these group differences were while
protecting the analysis error rate, and showed that the military/veteran groups were both
significantly older than their respective civilian control groups. No differences were found
between odorant condition groups for either the Veteran or Control groups. Age values for each
group can be seen in Table 2.
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Table 2: Age Differences by Group
Group

n

Mean

Std Error

Lower 95%

Upper 95%

1. Veteran -

11

32.0909

2.1999

27.684

36.498

A

14

35.2143

1.9981

31.213

39.215

A

19

20.5789

1.6739

17.226

23.932

B

17

19.3529

1.7696

15.808

22.898

B

Odorant
2. Veteran - No
Odorant
3. Control Odorant
4. Control - No
Odorant

Note: Groups not connected by the same letter are significantly different.
Chi-Square tests were then utilized to explore demographic differences between groups.
With respect to ethnicity, no significant differences were found (χ2 18, n = 61,) p = 0.53.
Significant differences were found for level of education (χ2 9, n = 61,) p = 0.002, with veterans
having completed more bachelor and graduate degrees than the civilian sample. Significant
differences were also found with respect to marital status (χ2 6, n = 61,) p < 0.0001, with veterans
being married and divorced significantly more than the civilian, student population. A significant
difference was also found for ITQ scores, F(3,57) = 2.913, p = 0.042, which suggested veterans
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were less likely to experience presence as seen in Figure 5.

Immersive Tendencies Questionnaire Scores
130.0
125.0
120.0
115.0
110.0
105.0
100.0

108.5

112.5

122.2

123.5

Veteran Odorant

Veteran Control

Civilian Odorant

Civilian Control

Figure 5: IPQ Scores by Group

Preliminary Analyses
A series of t-tests were conducted comparing the odorant and no-odorant military groups
to isolate the effect of odorant on users’ sense of presence consistent with clinical use of VR with
odorants in the treatment of combat-related PTSD (Beidel, Frueh, Neer, & Lejuez, 2017). No
significant differences were found between odorant conditions, indicating those with military
backgrounds experienced similar levels of presence regardless of odorant condition, t(23) = 0.134, p = 0.894. These results were mirrored in the civilian groups as well, with odorants failing
to make a significant difference in reported presence on the IPQ, t(34) = -1.35, p = 0.179.
Physiological data recorded over the duration of the VE was divided into eight sequential
60-second epochs (henceforth referred to as ‘time’), with Respiratory Sinus Arrhythmia (RSA)
29

and High Frequency/RSA Power (HF/RSA) Power as the primary dependent variables. Veteran
RSA was examined utilizing a full factorial model to identify differences between service
members who received odorants compared to those who did not. This model revealed no
significant differences between odorant conditions, F(1, 21.98) = 1.269, p = 0.272. EDA was
also explored within the military groups and results indicated no significant differences in EDA
between odorant conditions, F(1, 21.93) = 0.680, p = 0.418. Taken together, these findings
indicated that within those subjects with military experience, odorants did not appear to make
any significant difference in physiological functioning, which ran counter to this study’s a priori
hypotheses. The combined IPQ scores can be seen in Figure 6. Thus, more complex analyses
were then conducted to further contrast potential differences that may be attributed to odorant or
participant experience.

Combined Presence Scores
64
62
60
58
56
54
52
50

Odorant

No Odorant

Figure 6: Combined IPQ Scores
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Full Model Analyses
Presence
The first scientific aim of this study was to determine if the delivery of odorants
increased perceived presence for the entire duration of the VE task. A 2x2 ANCOVA examining
presence scores on the IPQ, while covarying for scores on the ITQ, failed to find statistically
significant differences between those who received odorants and those who did not, F(4, 56) =
0.965, p = 0.329, r2 = 0.11. This result indicated that statistically, each group experienced similar
levels of presence regardless of odorant condition. Presence ratings on the VAS were also
examined utilizing an identical ANCOVA. While this result was closer to reaching statistical
significance (F(4, 56) = 1.959, p = 0.167, r2 = 0.10), definitive differences were absent.
Examination of group means did reveal a pattern of scores consistent with H1, with those
receiving odorants reporting greater presence (LSM = 69.89, SE 3.79) than those who did not
receive odorants (LSM = 62.57, SE = 3.59).
A 2x2 ANCOVA was then utilized to explore the IPQ subscales that include Spatial
Presence, Involvement, and Realism. No significant differences were found for Spatial Presence
(F(4, 56) = 1.258, p = 0.29, model r2 = 0.08) or Involvement (F(4, 56) = 0.532, p = 0.71). A
significant difference for background was found when examining Realism (F(4, 56) = 8.597, p =
0.004) which indicated that those with a military background perceived the VE to be more
realistic (LSM = 17.43, SE = 0.79) than their civilian peers (LSM = 14.31, SE = 0.65) regardless
of odorant condition.
Three scripted events were included within the virtual environment which included (1)
passing a grove of palm trees, (2) an RPG attack on the lead vehicle of the convoy, and (3)
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crossing beneath a potentially hostile bridge. Participants were prompted after each event during
the VE to verbally provide their current presence rating on a scale of 1-7 (seven being “most
there”). For the palm grove event (event one), no significant effects for odorant (F(4, 55) =
0.668, p = 0.417) or the background*odorant interaction (F(4, 55) = 1.646, p = 0.204) were
found, though a main effect for background approached significance (F(4, 55) = 3.29, p = 0.074).
Analysis of the second event, which depicted an enemy RPG strike against the first vehicle
immediately ahead of the participants vehicle, showed a statistically significant main effect for
background (F(4, 56) = 7.546, p = 0.008), indicating that those with military backgrounds
perceived higher presence (LSM = 5.65, SE = 0.22) during this event than the controls (LSM =
4.82, SE = 0.11). Event three (passing under a potentially hostile bridge) had comparable results
to event one, with both odorant and the background*odorant interaction effects failing to meet
statistical significance. The background condition approached significance (F(4, 56) = 3.425, p =
0.0695) with participants with military backgrounds reporting higher levels of presence (LSM =
5.19, SE = 0.25) compared to controls (LSM = 4.57, SE = 0.20).
Physiological Responses
Heart Rate Variability (HRV)
Linear Mixed Modeling (LMM) was used to explore the effects of odorants and military
background on HRV, with lower HRV indicating more arousal. A main effect for background
was identified, F(1, 55.97) = 4.707, p = 0.035, r2 = 0.81, which showed veterans had
significantly less variation (LSM = 6.08, SE = 0.22) during the interbeat period than controls
(LSM = 6.84, SE = 0.20). This result suggested that veterans experienced more arousal than the
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civilian controls when engaged with the VE. Full model effects can be seen in Table 3. A main
effect for time was also found, F(1, 55.97) = 2.823, p = 0.007, as seen in Figure X.
Table 3: RSA Main Effects

Background
Odor
Time
Background*Odor
Background*Time
Odor*Time
Background*Odor*Time

Main Effect

DF
1
1
7
1
7
7
7

F Ratio
4.707
0.379
2.823
1.776
0.864
0.932
0.675

r2 = 0.81
p
0.034
0.541
0.007
0.188
0.535
0.481
0.693

Figure 7: RSA by Time

RSA was then examined using the 60-second, post-scripted time, the results of which can
be seen in Table 4.
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Table 4: RSA Effects by Scripted Event
Effects, Event 1
Odorant
Background
Background*Odorant

Sum of Squares
2.846
5.666
7.167

F Ratio
2.323
4.624
5.849

p
0.133
0.035
0.018

Effects, Event 2
Odorant
Background
Background*Odorant

0.271
9.004
0.464

0.143
4.772
0.246

0.705
0.033
0.621

Effects, Event 3
Odorant
Background
Background*Odorant

0.978
7.354
1.922

0.756
5.686
1.486

0.388
0.02
0.227

Significant effects for background and the background*odorant interaction were found
immediately following event one. Following this event, veterans displayed significantly lower
RSA (LSM = 6.18, SE = 0.22) than controls (LSM = 6.81, SE = 0.18). The background*odorant
interaction indicates that the veteran group who did not receive odorants was significantly more
aroused than the control groups, though statistically similar to the veteran odorant condition, as
seen in Table 5.
Table 5: Background*Odorant RSA Interaction for Event 1
Group
Veteran, Odorant
Veteran, No Odorant
Civilian, Odorant
Civilian, No Odorant

Least Sq Mean
6.76
5.607
6.682
6.944

Std Error
0.333
0.307
0.253
0.268

Note: Groups not connected by the same letter are significantly different.
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A
A
B
B

A main effect for background was also seen immediately following event two (F(3, 56) =
4.772, p = 0.033), during which veterans again showed significantly lower RSA (LSM = 6.04, SE
= 0.28) than controls (LSM = 6.83, SE = 0.22). This pattern of responding continued following
event three (F(3, 56) = 5.686, p = 0.020), with veterans displaying lower RSA (LSM = 6.25, SE =
0.23) than their control counterparts (LSM = 6.97, SE = 0.18).
High Frequency/ Respiratory Sinus Arrhythmia (HF/RSA) power was also examined to
identify differences in parasympathetic activation between groups and conditions. LMM was
again utilized to explore the background, odorants, background*odorant interaction, and baseline
HF/RSA effect terms. This model had an R2 of 0.44, accounting for 44% of the variance within
the model. The a priori hypothesis stated that both those with military backgrounds, those who
received odorants, and the military background/odorant group, would experience greater
parasympathetic activation. This hypothesis was not supported by the data, as odorant condition
(F(1, 55.22) = 0.013, p = 0.908, r2 = 0.41), background (F(1, 55.11) = 0.407, p = 0.526), and the
odorant*background interaction (F(1, 55.11) = 0.086, p = 0.769) failed to reach statistical
significance. Further examination of the LSM for the odorant condition revealed marginally
higher HF/RSA peak power in those who received odorants (LSM = 0.19, SE = 0.006) compared
to those who received no smells (LSM = 0.18, SE = 0.006). Inspection of HF/RSA also revealed
minute differences favoring those without military backgrounds (LSM = 0.19, SE = 0.005) over
their service member counterparts (LSM = 0.18, SE = 0.006). These main effects can be seen in
Table 6.
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Table 6: HF/RSA Effects
Main Effect
Background
Odor
Segment Number
Background*Odor
Background*Segment Number
Odor*Segment Number
Background*Odor*Segment Number

df
1
1
7
1
7
7
7

F Ratio
0.387
3.034
0.745
0.318
0.919
0.682
1.775

p
0.536
0.087
0.633
0.574
0.491
0.686
0.09

Electrodermal Response (EDA)
Significant group differences were identified in baseline tonic SCL between those with
military service and their civilian counterparts, t(58) = 2.430, p = 0.018, as seen in Figure 8.

Figure 8: Baseline Tonic SLC by Group

36

Time segments utilized for RSA and HF/RSA were also examined to determine if differences
existed within the electrodermal response, this study’s index of sympathetic nervous system
activity. A LMM was constructed which accounted for baseline response levels, odorant
condition, military background, and time. When examining total SCR responses, regardless of
the presence or absence of a scripted event, no significant differences were seen for odorant
condition (F(1, 54.93) = 0.913, p = 0.343), background (F(1, 54.95) = 0.069, p = 0.793), or the
interaction term (F(1, 54.87) = 0.010, p = 0.918, Table 7). This model had an R2 = 0.77 and
indicated that participants across conditions, backgrounds, and exposure time had similar
numbers of total SCR events, though it is probable that the constant carries the majority of the
accounted residual. No SCRs included in this model were classified as Event-Related.
Table 7: Total SCRs
Effect

df

F Ratio

p

Background
Odor
Segment
Background*Odor
Background*Segment
Odor*Segment
Background*Odor*Segment
Total SCRs, Baseline

1
1
7
1
7
7
7
1

0.069
0.913
30.137
0.01
0.846
2.687
1.569
98.453

0.793
0.343
<0.000
0.918
0.549
0.01
0.142
<0.000

Tonic Skin Conductance Level (SCL) was also examined to determine if odorants or
background influenced mean SCL after removing artifacts introduced by SCRs. This analysis
utilized the same LMM as total SCR but with SCL set as the dependent variable. After
controlling for baseline measurements, no significant effects were found as seen in Table 8.
These results indicate that regardless of background or odorant condition, similar levels were
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observed. Tonic Period was also assessed to determine if participants varied in the duration of
SCR responses utilizing this LMM. These results were not statistically significant and indicated
similar tonic periods regardless of condition or background as seen in Table 9.
Table 8: Tonic SCL Effects and Interaction Term Across VE
Term
Background
Odor
Background*Odor
Note: Model R2 = 0.98

DF
1
1
1

DF Error
55.04
55.03
55.03

F Ratio
0.2
0.218
2.356

p
0.656
0.642
0.13

F Ratio
1.225
0.044
0.002

p
0.273
0.833
0.964

Table 9: Tonic Period Effects and Interaction Term Across VE
Term
Background
Odor
Background*Odor
Note: Model R2 = 0.77

DF
1
1
1

DF Error
55.21
55.2
55.16

15-second time segments where analyzed utilizing a LMM. Significant main effects for Odorant,
F(1,56) = 4.43, p = 0.039 (r2 = .99), and Background, F(1,56) = 5.83, p = 0.019 were identified, which
suggested those who received odorants had higher SCL than those without as seen in Table 10. Further,
veterans had lower SCL than their civilian counterparts
Table 10: Post-Event SCL
Effect
Odor
Background
Event
Odor*Background
Odor*Event
Background*Event
Odor*Background*Event

df
1
1
2
1
2
2
2

DFDen
56
56
112
56
112
112
112
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F Ratio
4.439
5.832
1.92
2.046
0.456
0.893
0.010

p
0.039
0.019
0.151
0.158
0.634
0.412
0.989

Note: Model R2 = 0.05
Table 11: Mean SCL, Scripted Events
Term
Background
Odor
Background*Odor
Note: Model R2 = 0.99

DF
1
1
1

DF Error
55
55
55

F Ratio
0.271
1.311
2.56

p
0.604
0.257
0.115

DF

DF Error

F Ratio

p

1
1
1

55
55
55

5.369
2.837
0.39

0.024
0.098
0.535

Table 12: Tonic Period, Scripted Events
Term
Background
Odor
Background*Odor
Note: Model R2 = 0.99

Tonic Period was analyzed as seen in Table 12. A significant main effect was found for
background, which indicated that those with military backgrounds spent significantly less time
without phasic EDA (LSM = 7.6sec, SE = 1.666) compared to controls (LSM = 12.5sec, SE =
1.353). In other words, service members’ SCRs occurred over longer periods of time, but at
similar magnitudes, as controls. The main effect for odorants and the background*interaction
term were not statistically significant.
EDA was also examined pre- and post-event do identify potential differences in SCL
immediately before and after an event. 15-seconds before and after (30 seconds total) were
analyzed via LMM. Significant effects were found for odorants and background, but not for
time. These results indicated that those with military backgrounds had lower SCL, and those who
received odorants, had greater levels of SCL (Table 13). SCL trends were also examined across
time by group. These are seen in Figure 9.
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Table 13:Pre/Post Event SCL
Effect
Odor
Background
Time
Odor*Background
Odor*Time
Background*Time
Odor*Background*Time

df
1
1
1
1
1
1
1

Error
56
56
56
56
56
56
56

F Ratio
4.474
5.962
2.746
2.087
0.430
2.322
0.703

p
0.038
0.017
0.103
0.154
0.514
0.133
0.405

Note: r2 = 0.98

Figure 9: SCL Across Time
Note: Vertical lines represent events one, two, and three, respectively.
A more complex pre/post event mixed model was also run to examine the effects of
odorants and experience immediately before and after the scripted events. This analysis utilized
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resampled data (20hz, or 20 samples per second) for ten seconds immediately before and after
each scripted event as seen in Table 14.
Table 14: EDA Event Analyses
Event 1 Effects (r squared = 0.98)

DF

DFDen

F Ratio

Prob > F

Background

1

57.29

9.186

0.004

Odor
Event 1 Effects
Time
Background*Odor
Background*Event 1
Background*Time
Odor*Event 1
Odor*Time
Event 1*Time
Background*Odor*Event 1

1
1
1
1
1
1
1
1
1
1

57.29
54.49
54.84
57.29
54.49
54.84
54.49
54.84
54.51
54.49

5.076
0.000
0.325
2.519
0.636
0.001
0.154
0.030
0.004
0.142

0.028
0.985
0.571
0.118
0.429
0.976
0.696
0.864
0.948
0.708

Event 2 Effects (r squared = 0.98)
Background
Odor
Time
Event 2
Background*Odor
Background*Time
Background*Event 2
Odor*Time
Odor*Event 2
Time*Event 2
Background*Odor*Event 2

DF
1
1
1
1
1
1
1
1
1
1
1

DFDen
57
57
57.1
57.08
57
57.1
57.08
57.1
57.08
57.1
57.08

F Ratio
6.740
3.846
2.926
0.462
2.438
0.205
1.708
0.108
0.868
0.154
0.884

Prob > F
0.012
0.055
0.093
0.500
0.124
0.652
0.197
0.744
0.355
0.696
0.351

Event 3 Effects (r square = 0.99)
Background
Odor
Time
E3
Background*Odor
Background*Time
Background*E3
Odor*Time

DF
1
1
1
1
1
1
1
1

DFDen
57.03
57.03
56.77
56.75
57.03
56.77
56.75
56.77

F Ratio
6.105
4.954
0.000
0.432
2.897
0.037
0.076
1.384

Prob > F
0.017
0.030
0.998
0.514
0.094
0.849
0.784
0.244

Odor*E3
Time*E3
Background*Odor*E3

1
1
1

56.75
56.82
56.75

0.888
0.153
0.238

0.350
0.697
0.628

Statistically significant main effects were observed for background and odorant
conditions, but were absent across interactions with the dichotomous event (En) marker,
suggesting no differences were observed as the resulting factor combination. These significant
41

differences also suggested odorants resulted in increased presence, and that civilians experienced
greater EDA than those with military service, which was consistent with previous analyses.
Event 1
Odorant
No Odorant

Least Sq Mean
12.359
7.444

Std Error
1.580
1.504

Veteran
Civilian

Least Sq Mean
6.595
13.207

Std Error
1.679
1.392

Event 2
Odorant
No Odorant

12.070
7.610

1.646
1.568

Veteran
Civilian

6.888
12.792

1.751
1.451

Event 3
Odorant
No Odorant

12.694
7.489

1.693
1.613

Veteran
Civilian

7.202
12.980

1.801
1.492

MANCOVA
In order to fully investigate relationships within our model, multiple MANCOVA
analyses were conducted on the main RSA and HRV datasets, which can be seen in Table 14.
Table 15: Physiological MANOVAs
Total SCRs
Intercept
Background

Odorants
Background*Odorants
Mean SCL
Intercept
Background

Odorants
Background*Odorants
Tonic SCL
Intercept
Background

df
1
1
1
1

Error
53
53
53
53

F Ratio
107.454
0.948
1.023
3.156

P
<.0001
0.334
0.316
0.081

df
1
1
1
1

Error
53
53
53
53

F Ratio
67.601
5.95
2.951
1.968

P
<.0001
0.018
0.091
0.168

df
1
1

Error
53
53

F Ratio
67.163
5.842

P
<.0001
0.019
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Odorants
Background*Odorants

1
1

53
53

3.009
1.968

0.088
0.166

RSA
Intercept

df
1
1
1
1

Error
53
53
53
53

F Ratio
1646.559
3.333
0
2.09

P
<.0001
0.073
0.996
0.154

df
1
1
1
1

Error
53
53
53
53

F Ratio
952.859
0.68
3.635
0.205

P
<.0001
0.413
0.062
0.652

Background

Odorants
Background*Odorants
HF/RSA
Intercept
Background

Odorants
Background*Odorants

As with the LMM, general statistical support was observed for a background main effect.
Odorants did not reach statistical significance in these analyses. Relationships between pre- and
post-experimental STAI scores were examined as well to determine if anxiety correlated with
physiological responses, as seen in Tables 15 and 16, respectively.
Table 16: Pre-Exposure STAI/Physiological Correlations
1
2
3
4
5
6

Pre Exposure
STAI Pre Exp
Total SCRs, Seg 1
Tonic SCL, Seg 1
Mean SC, Seg 1
RSA, Seg 1
HF/RSA Peak Power, Seg 1

1
1.00
-0.02
-0.14
-0.13
-0.22
-0.26
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2

3

4

5

6

1.00
0.66
0.67
-0.22
-0.03

1.00
1.00
-0.12
0.11

1.00
-0.11
0.10

1.00
0.10

1.00

Table 17: Post Exposure STAI/Physiological Correlations
1
2
3
4
5
6

Post-Exposure
STAI Post Exp
Total SCRs, Seg 1
Tonic SCL, Seg 1
Mean SC, Seg 1
RSA, Seg 1
HF/RSA Peak Power, Seg 1

1
1.00
-0.10
-0.17
-0.17
-0.22
-0.09

2

3

4

5

6

1.00
0.66
0.67
-0.22
-0.03

1.00
1.00
-0.12
0.11

1.00
-0.11
0.10

1.00
0.11

1.00

Secondary Analyses
Anxiety
Trait Anxiety scores on the STAI were examined to identify any group differences prior
to principle analyses. An ANOVA examining STAI-Y2 (trait anxiety) did not find statistically
significant differences between groups (F(3, 57) = 1.388, p = 0.255). These results indicate that
each group had similar levels of trait anxiety as measured by the STAI prior to participating in
the experimental task. A 2x2 ANCOVA was then utilized to detect differences in state anxiety
before and immediately after engaging in the VE. This model used individual trait anxiety as a
covariate and found the main effect for time approached significance, which indicated mild
increases in anxiety following the VE task (LSM = 32.86, SE = 0.95) compared to baseline (LSM
= 30.97, SE = 0.95.) No other effects approached or achieved statistical significance in this
model as seen in Table 17.
Table 18: State Anxiety Fixed Effect Tests
Term
Background
Odor
Time
Background*Odor
Note: Model R2 = 0.78

DF
1
1
1
1

DF Error
56
56
57
56
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F Ratio
2.790
1.224
3.419
1.674

p
0.100
0.273
0.069
0.200

Odorant Valence, Familiarity, and Intensity
Prior to the experiment, participants were asked to rate each odorant in terms of
familiarity, pleasantness, and intensity. A one-way ANOVA was used to identify significant
differences by group. No significant differences were found between groups on pleasantness,
familiarity, or intensity. P-values for these one-way ANOVAs can be seen in Table 18, with
individual odorant means and standard errors in Table 19.
Table 19: One-way ANOVAs, Valence*Group
Pleasantness

Familiarity

Intensity

p
Smoke

0.55

0.33

0.11

Body Odor

0.99

0.18

0.90

Diesel Fuel

0.24

0.67

0.16

Garbage

0.81

0.51

0.53
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Table 20: Odorant Valence Means by Group
Smoke
Group

Body Odor

Pleasant

SE

Familiar

SE

Intense

SE

Pleasant

SE

Familiar

SE

Intense

SE

Veteran - Odorant

5.82

0.45

5.73

0.46

4.27

0.29

5.36

0.30

3.27

0.35

3.09

0.27

Veteran - No Odorant

5.36

0.40

5.21

0.41

5.07

0.26

5.29

0.27

3.14

0.31

3.21

0.24

Control - Odorant

5.00

0.34

5.16

0.35

4.32

0.22

5.32

0.23

2.53

0.27

3.00

0.21

Control - No Odorant

5.29

0.36

4.65

0.37

4.59

0.23

5.29

0.24

2.53

0.28

3.00

0.22

Diesel Fuel
Group

Garbage

Pleasant

SE

Familiar

SE

Intense

SE

Pleasant

SE

Familiar

SE

Intense

SE

Veteran - Odorant

4.09

0.38

4.00

0.46

4.45

0.23

7.27

0.34

5.45

0.29

11.00

4.09

Veteran - No Odorant

4.50

0.34

4.50

0.40

4.29

0.20

6.93

0.30

5.07

0.26

14.00

4.00

Control - Odorant

4.21

0.29

4.58

0.35

4.68

0.18

7.16

0.26

5.37

0.22

19.00

3.58

Control - No Odorant

3.59

0.31

4.12

0.37

4.88

0.19

7.29

0.27

5.59

0.23

17.00

3.24

Simulator Sickness
Simulator sickness was also examined to assess for new or worsening symptoms caused
by the VR task. This was done by examining the effects of odorants, background, and time
across the model. No significant differences were found for odorant condition (F(1, 57) = 0.137,
p = 0.712) or the odorant*background interaction (F(1,57) = 0.236, p = 0.628). A main effect for
background did approach significance (F(1,57) = 3.970, p = 0.051), indicating that those with
military backgrounds reported a greater number of symptoms consistent with simulator sickness
(LSM = 4.2, SE = 0.86) compared to the controls (LSM = 1.95, SE = 0.72). Previous research has
shown that those with expertise in given situations may be more susceptible to SS (McGuinness,
Bouwman, & Forbes, 1981).
Attention
After the simulated exposure task was completed, participants answered several questions
about stimuli that may or not have been included within the VE. These stimuli were multimodal
in nature and included visuals (a camel, helicopter, blue and white police vehicle, and collapsed
bridge), tactile feedback (yes/no), odorants (yes/no), and temperature changes (yes/no). This
battery of questions served as an index of attention as it is difficult to utilize objective measures
of attention (such as eye trackers) with current HMD technology. Overall, 100% of participants
correctly reported receiving visuals through the HMD. A large majority (81%) correctly
identified they experienced tactile feedback during the EXP. Most participants (77%) across all
groups reported receiving odorants, while only 30 participants were administered odorants
during the EXP. Those who did not receive odorants were far more accurate in determining if
they been administered odorants than the actual odorant condition. Most individuals were also

correct in determining if they had been administered odorants (58%), while 62% correctly
identified the presence of a white and blue police vehicle within the VE. Finally, all participants
correctly identified that an object (a destroyed bridge) was not present in the scenario. The
overall pattern of correct responses on the attention items indicated no significant differences in
attention between groups. These results indicated all groups exerted fair effort during the
experimental tasks.
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DISCUSSION
The primary purpose of this study was to determine if odorants or military experience
influenced users’ perceived presence during a virtual convoy in a Middle Eastern environment.
The a priori hypotheses were that the administration of odorants, a positive history of military
deployment, and the interaction of the two, would result in significantly higher levels of
presence. Further, it was hypothesized that odorants and military experience would moderate
HRV and EDA.
The hypotheses regarding presence were not supported by the data collected in this
sample. Regardless of the presence or absence of odorants, participants experienced similar
levels of presence during the simulator exposure task. Scores on the VAS mirrored these results.
Individual group means did trend in the hypothesized directions with those who received
odorants reporting an average of two points higher on the IPQ, and seven points on the VAS.
However, subscale analysis of the IPQ differed from previous research, which indicated
significantly different scores on the involvement subscale, favoring odorants (Munyan, Neer,
Beidel, & Jentsch, 2015). Those with military service also reported substantially higher levels of
realism after engaging with the VE. Increasing realism may be beneficial during psychotherapy
if incremental improvements in CS realism translate to improving treatment outcomes. It is
possible that the observed significant effects described here accounted for enough variance
within the model that further effects would require additional power to detect. Raw mean
analysis of group*odorant effects trended in the hypothesized directions but were not statistically
significant. Another hypothesis is that the groups were more dissimilar than planned.
Despite previous anecdotal and empirical evidence favoring odorants, significant effects
were far more likely to be attributed to military experience within this sample. Regarding
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presence, main effects for a military background were found during the second scripted event (an
RPG ambush) during which those with deployment experience were more present than controls.
This was unexpected as we believed those with combat experience might be more critical of the
VE. It is possible warfighters were particularly engaged with this event because of their
experience. The urban environment may have been a “red flag” for those who have deployed,
whereas those without military training did not differentiate between environments and their
associated (and simulated) risk despite the included narration during the task.
Examination of HRV also showed those who had deployed previously had significantly
less variation during the interbeat period, indicating significantly more parasympathetic arousal
than controls. While there was moderate support of our military background hypotheses, HRV
analyses failed to statistically support the hypothesis that odorant would moderate RSA. We also
hypothesized electrodermal responses of both greater magnitude and frequency in those who
receive odorants and in participants with military experience. The data collected did not support
either of these hypotheses. In fact, the only main effect that achieved statistical significance was
tonic period, which indicated service member’s responses, though similar in frequency, had
longer durations than controls. This may be a result of military training or diverse levels of
vigilance throughout the VE. Unfortunately, this study lacked temporal resolution that would
enable causal inferences. The lack of significant EDA differences may also be (to some degree) a
lack of state anxiety generated by the VE. Despite scripting several potentially dangerous events
into the VE (RPG Ambush, potential IED sites, and roadside debris), which are often specifically
associated with danger in contemporary combat zones, reported anxiety was less than
anticipated.

50

The lack of anxiety response within the military population may be because all military
participants had engaged in convoy operations overseas, some with multiple deployments. This
degree of experience may have blunted an anxiety response for many reasons. For example,
participants may have realized that no dangerous outcome was physically possible given the
simulated nature of the VE. Another reason for this finding may be that those with more time
deployed had habituated to anxiety associated with military operations. This hypothesis was
tested utilizing a bivariate analysis, which did not show a significant relationship between time
deployed and state anxiety during the VE. The nature of our nonclinical sample may also be a
factor; those with PTSD (and perhaps, the most to fear) were excluded from this study, which
may introduce a ceiling effect with respect to anxiety.
An important theoretical question also lingers; is presence required for exposure therapy
to work? Imaginal EXP has been demonstrated to be effective repeatedly, without the use of
virtual reality of other external stimuli. When done correctly, it is likely that presence is high and
is thus a byproduct of the exposure when patients are actively engaged during therapy. Our
hypotheses suggested that the addition of odorants to EXP might further increase presence, thus
boosting patient engagement, with the hopes that increased engagement via presence may then
result in tertiary effects, such as improved outcomes or shorter episodes of care. A similar trend
was currently found by Mota et al. (2015), who noted that ratings of vividness during EXP
predicted treatment outcome. A valid concern regarding the inclusion of odorants is that odorant
specificity may be subject to the “uncanny valley” (Mori, 1970), by which incorrect stimuli may
produce effects worse than no stimulant at all. Further research may be required to explore
odorant specificity as it relates to EXP.
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Participants also rated odorant valences as a part of this study, with all groups rating each
quality (pleasantness, familiarity, and intensity) in a similar fashion. Despite measuring odorant
valence and individual differences in immersive tendencies, statistical evidence supporting
anecdotal statements encountered throughout the combat-related PTSD literature was not found.
While this study did find limited evidence that odorants increase presence and moderate RSA
and EDA, these findings were not statistically robust enough to drive clinical decision-making.
There are, however, several ways to methodologically improve upon this study in the future.

Limitations and Future Directions
In this study, veteran participants were nearly a decade older on average than the
nonmilitary controls within this sample. Further, the military sample was also more likely to be
married and have completed more formal education. While some difference in age was expected
due to the nature of military service, which requires at least an 8-year commitment (only some of
which must be active duty), we did not anticipate a mean difference of greater than 10 years. The
differences between groups may also be less obvious. For instance, it is estimated that 5.2% of
the US population has served in the armed forces (Chalabi, 2015). It has also been shown that
soldiers are more likely to come from high-income areas and have completed more education
than civilian peers . SES data were not collected during this study, nor would it be appropriate to
readily interpret educational differences that existed between groups within this sample, as all
control subjects were actively pursuing degrees at an institution of higher education. While no
research could be identified that offered a theoretical rationale for age or education influencing
presence, the possibility cannot be ruled out. An improved approach might include recruiting
adults closer in age, which may then better account for both educational and marital differences
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and better represent the broader adult population rather than the college population described
here.
It was also noted that 33% of participants were unable able to correctly identify if
odorants were delivered during their experimental task. While “true negative” participants were
more accurate identifying the absence of odorants, it is possible the odorants utilized where
insufficient in duration or intensity during the task for certain individuals which may have
impacted presence ratings. Similarly, no ratings of odorant fidelity were collected to determine if
participants perceived the odorants as scene appropriate. Increased presence would likely only
occur if odorants were high fidelity with respect to the VE.
Temporal resolution within the study was also insufficient to permit additional analyses
of interest. For example, comparing physiological responses during odorant administration or
narrative delivery may have been revealing. Due to equipment limitations, “flagging” these
events during the experiment was not possible.
Thus far, the terms “memory,” “experience,” and “background” were used
interchangeably. This was not in error, but rather an attempt to honestly convey the rift between
internal and external validity whilst “bootstrapping” military participants’ deployment
experience overseas to an artificial virtual environment to assess what we believed to be a
somewhat common military mission. This “muddying of the waters” was unavoidable with a
nonclinical sample who may not have experienced and perceived a convoy operation precisely as
simulated during the exposure task. With a true clinical sample utilizing VEs designed around
their specific traumatic event would likely experience significantly greater levels of anxiety and
presence. Specifically, matching trauma-related odorants to trauma-focused therapy eliminates
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the problems inherent in a well design, internally valid research study where findings may not
generalize outside of the laboratory. Given the highly personal nature of PTSD, one might argue
that sacrificing internal validity (by customizing odorant/trauma scenes to each subject) would
lead to significantly more meaningful data (which would be difficult to control for, statistically
speaking).
Utilizing a clinical sample of individuals with actual traumatic, episodic memories and
customizing the VE to match their individual event may be the only method to accurately assess
the effect of odorants due to the number of variables involved in memory formation. Further,
contrasting the clinical groups to similar military controls would be a significant improvement,
as it would allow further control to distinguish between the effects of military training,
deployment experience, and trauma. While this research design would be complex, the results
may be more meaningful given the variability seen in PTSD diagnoses and mental health in
general. This research would also serve as a meaningful leap towards exploring the true field
value and utility of odorant augmentation during exposure therapy.
Conclusion
Exposure therapy continues to be a first-line intervention for anxiety and trauma-related
disorders. Exposure therapy is already being augmented with virtual reality with great success
(Beidel et al., 2017). However, the specific effects of odorants remain relatively underexplored.
The contrast between odorant conditions in this study may have improved with groups better
matched for age and education, with further emphasis on external validity. Despite the
limitations of this study, several noteworthy findings were discovered. Those with military
backgrounds reported the VE to be more realistic, which may prove to have utility given the

54

importance of realism during EXP. Further, service members also experienced more decreased
RSA than controls, indicating that VEs alone may improve performance during exposure. It is
our hope that clinicians and researchers alike will continue to embrace VE augmentation and
research, and that future research addresses and overcomes the challenges discussed here.
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APPENDIX B: OUTCOME VARIABLE CORRELATIONS
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1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

ITQ
IPQ
IPQ (SP)
IPQ (Involvement)
IPQ (Realism)
STAI (State, Post)
STAI (State, Pre)
STAI (Trait)
SSQ (Pre)
SSQ (Post)
Anxiety (Pre)
Anxiety (Post)
Video Game Use
Palm Grove
RPG Ambush
Bridge Rating

1
1.00
-0.03
-0.02
0.05
-0.06
-0.21
-0.30
-0.13
-0.19
-0.15
-0.19
-0.16
0.25
0.04
-0.02
-0.05

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

1.00
0.86
0.65
0.79
0.34
0.20
0.09
0.22
0.33
0.20
0.40
-0.04
0.55
0.64
0.57

1.00
0.46
0.47
0.22
0.15
0.06
0.11
0.16
0.04
0.27
0.00
0.47
0.50
0.48

1.00
0.27
0.20
0.08
0.02
0.24
0.26
0.14
0.28
-0.01
0.43
0.35
0.42

1.00
0.35
0.23
0.14
0.18
0.35
0.29
0.37
-0.07
0.37
0.56
0.39

1.00
0.70
0.63
0.47
0.73
0.76
0.81
-0.25
0.19
0.24
0.31

1.00
0.83
0.56
0.58
0.72
0.53
-0.14
0.23
0.08
0.20

1.00
0.49
0.52
0.68
0.45
-0.22
0.21
-0.04
0.12

1.00
0.84
0.46
0.43
-0.19
0.10
0.14
0.23

1.00
0.61
0.65
-0.27
0.09
0.22
0.27

1.00
0.75
-0.21
0.20
0.14
0.21

1.00
-0.26
0.24
0.34
0.36

1.00
-0.09
-0.19
-0.13

1.00
0.71
0.72

1.00
0.70

1.00
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